Clear All
11765 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
85766-0001-20 85766-0001 PREDNISONE Prednisone 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jun 19, 2025 In Use
61919-0342-20 61919-0342 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan 1, 2015 In Use
69097-0364-36 69097-0364 Bleomycin Bleomycin 15.0 [USP'U]/1 Chemotherapy Antitumor Antibiotic Carboxylic Acids and Amino Acids/Peptides Intramuscular, Intrapleural, Intravenous, Subcutaneous Mar 11, 2019 In Use
63539-0284-03 63539-0284 palbociclib Ibrance 75.0 mg/1 Chemotherapy Cyclin Dependent Kinase Inhibitor CDK 4/6 Oral Mar 30, 2020 In Use
59676-0600-56 59676-0600 Apalutamide ERLEADA 60.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Apr 1, 2019 In Use
72789-0509-15 72789-0509 PredniSONE PredniSONE Tablets, USP, 20 mg 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral May 22, 2025 In Use
83831-0142-50 83831-0142 CARBOplatin KYXATA 500.0 mg/50mL Chemotherapy Alkylating Agent Platinum Compound Intravenous Aug 11, 2025 In Use
51655-0803-27 51655-0803 ondansetron hydrochloride Ondansetron 8.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb 23, 2015 In Use
55700-0728-21 55700-0728 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Mar 1, 2019 In Use
00378-0315-93 00378-0315 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Jun 25, 2007 In Use
78206-0153-02 78206-0153 FINASTERIDE PROSCAR 5.0 mg/1 Ancillary Therapy Protective Agent 5-alpha Reductase Inhibitor Oral Jun 1, 2021 In Use
58458-0002-02 58458-0002 Azacitidine Azacitidine 100.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, Subcutaneous Jul 30, 2025 In Use
60219-1717-01 60219-1717 Lenalidomide LENALIDOMIDE 15.0 mg/1 Immunotherapy Immunomodulator Thalidomide Analog Oral Feb 12, 2025 In Use
70518-3913-00 70518-3913 Medroxyprogesterone acetate Medroxyprogesterone acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Nov 10, 2023 In Use
85043-0025-02 85043-0025 Leuprolide acetate Vabrinty 22.5 mg/.375mL Hormonal Therapy GnRH Agonist Subcutaneous Aug 4, 2025 In Use
70518-3913-01 70518-3913 Medroxyprogesterone acetate Medroxyprogesterone acetate 10.0 mg/1 Hormonal Therapy Progestin Oral Jul 4, 2024 In Use
70518-4191-03 70518-4191 PredniSONE PredniSONE 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Nov 6, 2024 In Use
70771-1058-07 70771-1058 Methotrexate Methotrexate 2.5 mg/1 Chemotherapy Antimetabolite Folic Acid Analog Oral Feb 9, 2017 In Use
71288-0119-91 71288-0119 Decitabine Decitabine 50.0 mg/20mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Jul 2, 2021 In Use
00310-0668-12 00310-0668 Olaparib Lynparza 100.0 mg/1 Chemotherapy Enzyme Inhibitor PARP Oral Aug 17, 2017 In Use
45629-0134-01 45629-0134 Tivozanib FOTIVDA 1.34 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR Oral Mar 10, 2021 In Use
70710-1575-08 70710-1575 Isotretinoin Isotretinoin 20.0 mg/1 Hormonal Therapy Immunomodulator Retinoic Acid Derivative Oral Jun 9, 2025 In Use
70529-0048-02 70529-0048 Triamcinolone Acetonide Protherix 40.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-Articular, Intramuscular Sep 1, 2018 In Use
54868-5231-02 54868-5231 Aprepitant Emend 80.0 mg/1 Ancillary Therapy Antiemetic Substance P/Neurokinin 1 Oral Jun 29, 2005 In Use
55648-0662-02 55648-0662 Granisetron Hydrochloride Granisetron Hydrochloride 0.1 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Mar 3, 2008 In Use

Found 11765 results — Export these results